Follow
Anand Singh
Anand Singh
Staff Scientist, National Cancer Institute, NIH
Verified email at nih.gov
Title
Cited by
Cited by
Year
Biogenesis of intronic miRNAs located in clusters by independent transcription and alternative splicing
P Ramalingam, JK Palanichamy, A Singh, P Das, M Bhagat, MA Kassab, ...
Rna 20 (1), 76-87, 2014
1822014
Iron oxide nanoparticles and magnetic field exposure promote functional recovery by attenuating free radical-induced damage in rats with spinal cord transection
A Pal, A Singh, TC Nag, P Chattopadhyay, R Mathur, S Jain
International journal of nanomedicine, 2259-2272, 2013
672013
Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application
P Majumder*, A Singh*, Z Wang, K Dutta, R Pahwa, C Liang, C Andrews, ...
Nature nanotechnology 16 (11), 1251-1259, 2021
472021
MicroRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis
A Singh, N Bhattacharyya, A Srivastava, N Pruett, RT Ripley, DS Schrump, ...
Molecular Therapy 27 (9), 1665-1680, 2019
402019
NADPH oxidase 4 modulates hepatic responses to lipopolysaccharide mediated by Toll-like receptor-4
A Singh, B Koduru, C Carlisle, H Akhter, RM Liu, K Schroder, RP Brandes, ...
Scientific reports 7 (1), 14346, 2017
382017
Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA
A Singh, JK Palanichamy, P Ramalingam, MA Kassab, M Bhagat, ...
Journal of Antimicrobial Chemotherapy 69 (2), 404-415, 2014
372014
Unconjugated hyperbilirubinemia
A Singh, T Koritala, I Jialal
352019
Increased inflammasome activity in subcutaneous adipose tissue of patients with metabolic syndrome
R Pahwa, A Singh, B Adams‐Huet, S Devaraj, I Jialal
Diabetes/Metabolism research and reviews 37 (3), e3383, 2021
212021
MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis
A Singh, N Pruett, R Pahwa, AP Mahajan, DS Schrump, CD Hoang
Molecular Therapy-Nucleic Acids 24, 669-681, 2021
182021
In vitro experimental models of mesothelioma revisited
A Singh, N Pruett, CD Hoang
Translational lung cancer research 6 (3), 248, 2017
182017
Expression pattern of PRM2, HSP90 and WNT5A in male partners of couples experiencing idiopathic recurrent miscarriages
K Kumar, D Deka, A Singh, P Chattopadhyay, R Dada
Journal of genetics 91, 363-366, 2012
172012
Normal mesothelial cell lines newly derived from human pleural biopsy explants
N Pruett, A Singh, A Shankar, DS Schrump, CD Hoang
American Journal of Physiology-Lung Cellular and Molecular Physiology 319 (4 …, 2020
142020
CpG Hypermethylation of the C-myc Promoter by dsRNA Results in Growth Suppression
M Mehndiratta, JK Palanichamy, A Pal, M Bhagat, A Singh, S Sinha, ...
Molecular Pharmaceutics 8 (6), 2302-2309, 2011
142011
Increased expression of platelet-derived growth factor associated protein-1 is associated with PDGF-B mediated glioma progression
VK Sharma, A Singh, SK Srivastava, V Kumar, NL Gardi, A Nalwa, ...
The International Journal of Biochemistry & Cell Biology 78, 194-205, 2016
102016
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
R Pahwa, J Dubhashi, A Singh, P Jailwala, A Lobanov, CJ Thomas, ...
Journal of Experimental & Clinical Cancer Research 41 (1), 208, 2022
52022
Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling
Z Li*, S Anand*, C Plaisier, N Pruett, RT Ripley, DS Schrump, CD Hoang
Translational oncology 12 (6), 859-870, 2019
42019
Current state of pleural-directed adjuncts against malignant pleural mesothelioma
AY Choi, A Singh, D Wang, K Pittala, CD Hoang
Frontiers in oncology 12, 886430, 2022
32022
Gene silencing and activation of human papillomavirus 18 is modulated by sense promoter associated RNA in bidirectionally transcribed long control region
MA Kassab, M Mudassir, A Singh, M N, M Bhagat, JK Palanichamy, ...
Plos one 10 (6), e0128416, 2015
32015
Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma
S Dixit, AY Choi, A Singh, K Pittala, N Pruett, CD Hoang
Journal of cancer metastasis and treatment 8, 2022
22022
miR-206 inhibits pleural mesothelioma by targeting an active KRAS/CDK4/CCND1 pathway
A Singh, R Pahwa, L Zhang, N Pruett, RT Ripley, DS Schrump, CD Hoang
Cancer Research 78 (13_Supplement), 523-523, 2018
22018
The system can't perform the operation now. Try again later.
Articles 1–20